Literature DB >> 9310246

Classical gene amplifications in human breast cancer are not associated with distant solid metastases.

K Driouch1, M H Champème, M Beuzelin, I Bièche, R Lidereau.   

Abstract

To determine the relationship between breast cancer progression and gene amplification, we screened 62 distant metastases and 122 primary breast tumours for the amplification of the proto-oncogenes MYC and ERBB2 and the 11q13 chromosomal region. Surprisingly, solid metastases showed an absence of gene amplification. These results suggest that the amplification of the proto-oncogenes MYC and ERBB2 and the 11q13 chromosomal region seem to be involved mainly in the genesis of the primary breast tumour rather than its progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310246      PMCID: PMC2228028          DOI: 10.1038/bjc.1997.462

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

Review 1.  Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; P S Steeg; W G Stetler-Stevenson
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

Review 2.  Molecular themes in oncogenesis.

Authors:  J M Bishop
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

3.  Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis.

Authors:  P H Watson; J R Safneck; K Le; D Dubik; R P Shiu
Journal:  J Natl Cancer Inst       Date:  1993-06-02       Impact factor: 13.506

4.  Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.

Authors:  B A Bonsing; P Devilee; A M Cleton-Jansen; N Kuipers-Dijkshoorn; G J Fleuren; C J Cornelisse
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

5.  c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

Authors:  E M Berns; J G Klijn; W L van Putten; I L van Staveren; H Portengen; J A Foekens
Journal:  Cancer Res       Date:  1992-03-01       Impact factor: 12.701

6.  A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer.

Authors:  I Bièche; M H Champème; R Lidereau
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

7.  Heterogeneity for allelic loss in human breast cancer.

Authors:  L C Chen; W Kurisu; B M Ljung; E S Goldman; D Moore; H S Smith
Journal:  J Natl Cancer Inst       Date:  1992-04-01       Impact factor: 13.506

8.  11q13 amplification in local recurrence of human primary breast cancer.

Authors:  M H Champème; I Bièche; S Lizard; R Lidereau
Journal:  Genes Chromosomes Cancer       Date:  1995-02       Impact factor: 5.006

9.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

Authors:  C Gillett; V Fantl; R Smith; C Fisher; J Bartek; C Dickson; D Barnes; G Peters
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

Review 10.  Gene amplification and tumor progression.

Authors:  O Brison
Journal:  Biochim Biophys Acta       Date:  1993-05-25
View more
  1 in total

1.  Combined analysis of copy number alterations by single-nucleotide polymorphism array and MYC status in non-metastatic breast cancer patients: comparison according to the circulating tumor cell status.

Authors:  R Nadal; M Salido; L Nonell; M Rodríguez-Rivera; E Puigdecanet; J L Garcia-Puche; M Macià; J M Corominas; M J Serrano; J A Lorente; F Solé
Journal:  Tumour Biol       Date:  2014-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.